Carvedilol USP/BP/EP is a pharmaceutical-grade beta-blocker indicated primarily for the management of heart failure, essential hypertension, and for improving survival rates post-myocardial infarction. This active pharmaceutical ingredient (API) is manufactured in compliance with United States Pharmacopeia (USP), British Pharmacopeia (BP), and European Pharmacopeia (EP) standards, ensuring high purity and quality. Carvedilol functions by blocking beta-adrenergic receptors, leading to reduced heart rate and blood pressure, which relieves strain on the cardiovascular system. It is frequently used as a standalone therapy or in conjunction with other cardiovascular drugs within clinical and hospital setups. Ideal for pharmaceutical companies, contract manufacturers, and research institutions involved in producing medications to treat cardiac conditions, Carvedilol USP/BP/EP offers reliable formulation compatibility and consistent bioavailability suitable for oral dosage forms.
Key Features
| Features | Description |
|---|---|
| Pharmacopoeia Standards | USP, BP, EP compliant |
| Primary Usage | Treatment of heart failure and hypertension |
| Additional Indication | Improves survival post-heart attack |
| Active Ingredient Form | Pure pharmaceutical-grade Carvedilol powder/API |
| Combination Therapy | Suitable for use alone or combined with other medications |
| Therapeutic Class | Beta-adrenergic blocking agent |
| Packaging | Supplied in bulk quantities tailored for pharmaceutical manufacturing |
| Quality Assurance | Batch-wise testing and certified compliance with pharmacopeial standards |
| Application | Used by pharmaceutical companies and healthcare product manufacturers |
| Attributes | Description |
|---|---|
| Chemical Name | Carvedilol |
| Molecular Formula | C24H26N2O4 |
| Molecular Weight | 406.47 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Practically insoluble in water, soluble in ethanol and chloroform |
| Assay | Typically 98.0% to 102.0% as per USP/BP/EP |
| Identification | Complies with USP/BP/EP identification tests |
| Loss on Drying | Not more than 1.0% |
| Heavy Metals | Not more than 20 ppm |
| Residue on Ignition | Not more than 0.1% |
| Storage Conditions | Store in a cool, dry place protected from light |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Carvedilol API is certified as per United States Pharmacopeia (USP), British Pharmacopeia (BP), and European Pharmacopeia (EP) standards, ensuring consistent quality and purity.
Yes, this Carvedilol API is suitable for formulations intended for use alone or in combination with other cardiovascular medications.
It should be stored in a cool, dry place, protected from light to maintain stability and effectiveness.
Yes, the API is compatible with oral dosage form manufacturing including tablets and capsules.
Each batch undergoes rigorous testing for assay, identification, heavy metals, loss on drying, and other pharmacopeial specifications.
Country Of Origin: India
Carvedilol is used alone or in combination with other medications to treat heart failure (condition in which the heart cannot pump enough blood to all parts of the body) and high blood pressure. It also is used to improve survival after a heart attack. Carvedilol is often used in combination with other medications.
